Recent News

• 11.19.2025 - Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Recent Filings

• 11.18.2025 - 8-K Current report
• 10.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.14.2025 - 8-K Current report
• 10.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.09.2025 - 8-K Current report
• 10.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.07.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 09.30.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership